Dyne Therapeutics
D

DYN

17.160
USD
0.12
(0.70%)
بعد الجلسة·17.160USD0.000(0.00%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
61,336
الربح لكل سهم
-4
العائد الربحي
-
P/E
-5
حجم السوق
3,215,560,285
نظرة عامة
أصول ذات صلة
AEP
AEP
D
American Electric Power Company
129.156
0.256(0.20%)
CNP
CNP
D
CenterPoint Energy
41.200
0.230(0.56%)
DTE
DTE
D
DTE Energy Company
139.720
0.490(0.35%)
139.730+0.010(+0.01%)
EIX
EIX
D
Edison International
60.190
0.190(0.32%)
60.180-0.010(-0.02%)
ES
ES
D
Eversource Energy
71.720
0.570(0.80%)
EXC
EXC
D
Exelon
46.260
0.640(1.40%)
FE
FE
D
FirstEnergy
47.010
0.515(1.11%)
NRG
NRG
D
NRG Energy
97.095
-0.975(-0.99%)
96.200-0.895(-0.92%)
PCG
PCG
D
PG&E
13.250
0.285(2.20%)
SO
SO
D
Southern Company (The)
93.605
1.145(1.24%)
93.590-0.015(-0.02%)
WR
WR
D
Corgi U.S. War Machine ETF
27.147
0.125(0.46%)
27.1470.000(0.00%)
المزيد

العنوان: Dyne Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

أسئلة شائعة حول سهم Dyne Therapeutics